Imperial College London, Level 7 East Wing, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK.
Int Orthop. 2013 Feb;37(2):321-6. doi: 10.1007/s00264-012-1654-y. Epub 2012 Sep 14.
The Ligament Augmentation and Reconstruction System (LARS) is a third generation of synthetic ligament, designed to overcome the issues of graft failure and synovitis which led previous generations of synthetic ligaments to fall out of favour. The theoretical benefits of LARS are appealing but this has not led to widespread uptake of the system in preference to autograft. The aim of this systematic review is to assess whether the evidence exists to support the use of LARS with respect to outcomes and complications.
A systematic search process was undertaken from January 1990 to June 2012 to identify primary evidence relating to the use of LARS in anterior cruciate ligament (ACL) single ligament reconstruction.
Nine studies were found meeting the search criteria including a single randomised controlled trial, two comparative series and six further observational case series. Overall the methodological quality of the studies was poor with follow-up to a maximum of five years. Reported outcome scores were good for LARS and comparable to autograft techniques. Complication rates were low and comparable to those published for autograft techniques within the wider literature. Two reported incidences of synovitis were identified in case reports.
The current literature supports the use of LARS in the short to medium term. However, high-quality studies with long-term follow-up are required to determine whether the use of LARS is preferable to autograft for ACL reconstruction over the longer term. Synovitis appears to be a rare complication closely related to imperfect graft positioning.
Ligament Augmentation and Reconstruction System(LARS)是第三代合成韧带,旨在克服前几代合成韧带因移植物失效和滑膜炎而失宠的问题。LARS 的理论优势具有吸引力,但这并没有导致该系统在偏好自体移植物方面得到广泛应用。本系统评价的目的是评估在 ACL 单束重建中使用 LARS 的证据是否存在,以支持其使用的结果和并发症。
从 1990 年 1 月至 2012 年 6 月进行了系统搜索过程,以确定与 LARS 在 ACL 单束重建中使用有关的原始证据。
共发现 9 项符合搜索标准的研究,包括一项随机对照试验、两项比较系列和另外六项观察性病例系列。总体而言,研究的方法学质量较差,随访时间最长为五年。报告的 LARS 结果评分良好,与自体移植物技术相当。并发症发生率低,与更广泛文献中报道的自体移植物技术相似。在病例报告中报告了两例滑膜炎的发生率。
目前的文献支持在短期至中期使用 LARS。然而,需要高质量的长期随访研究来确定在较长时间内使用 LARS 是否优于自体移植物进行 ACL 重建。滑膜炎似乎是一种罕见的并发症,与移植物定位不理想密切相关。